Ficha del valor · trimestre archivado
EOLS
Evolus, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
15Tenedores rastreados
0Δ titulares
14.12MAcciones mantenidas
$130.04MValor declarado
+1Nuevas posiciones
−1Cierres
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -3.9% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 63 | +6 | 23.25M | $161.16M | +10 | −4 |
| Q1 2026 | 59 | -7 | 18.93M | $77.97M | +3 | −10 |
| Q4 2025 | 66 | -1 | 24.04M | $159.85M | — | −1 |
| Q3 2025 | 17 | -1 | 17.27M | $106.03M | — | −1 |
| Q2 2025 | 15 | 0 | 14.12M | $130.04M | +1 | −1 |
| Q1 2025 | 12 | +2 | 7.19M | $86.49M | +2 | — |
| Q4 2024 | 10 | -1 | 6.42M | $70.90M | — | −1 |
| Q3 2024 | 10 | 0 | 4.64M | $75.21M | +1 | −1 |
| Q2 2024 | 10 | — | 4.38M | $47.51M | — | — |
Quién lo tiene en cartera · Q2 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (pasivo) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (pasivo) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (pasivo) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasivo) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 1.48M | +6.6% | $13.66M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (pasivo) | 1.41M | +1.7% | $12.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Geode Capital Management ✦ (pasivo) | 1.23M | -2.4% | $11.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Geode Capital Management ✦ (pasivo) | 1.23M | -2.4% | $11.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 957.74K | +9.2% | $8.82M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 957.74K | +9.2% | $8.82M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 581.86K | +135.1% | $5.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 581.86K | +135.1% | $5.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Renaissance Technologies ✦ | 341.40K | +318.4% | $3.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Wellington Management ✦ | 164.02K | +9.0% | $1.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 164.02K | +9.0% | $1.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 164.02K | +9.0% | $1.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Adage Capital Partners ✦ | 128.40K | -73.6% | $1.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 123.86K | -35.4% | $1.14M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Marshall Wace ✦ | 67.85K | Nuevo | $624,860 | 0.0% | New | 1 | SEC ↗ |
| 37 | Marshall Wace ✦ | 67.85K | Nuevo | $624,860 | 0.0% | New | 1 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 56.32K | +3.1% | $519,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 2.42K | — | $22,246 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 2.42K | — | $22,246 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $624,860 | 0.0% |
| Marshall Wace | $624,860 | 0.0% |
Posición cerrada
| Soros Fund Management | $11.98M | era 0.3% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 146 tenedores, 45.63M acciones, $187.01M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2025 ·
Metodología ·
Obtener esto a través de la API